Lung MRI for staging tumors and nodes
Part of Cancer, Lungs & breathing clinical trials.
This trial uses advanced lung MRI scans to get more detail on tumors and lymph nodes. It may help people with non-small cell lung cancer to get a clearer picture of their cancer stage without extra radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a primary non-small cell lung cancer (NSCLC) tumor that is at least 2 cm across on a CT scan.
- You have had a biopsy of the tumor, and it was big enough to test the PDL-1 level.
- Your staging CT scan showed that doctors are uncertain about the lymph nodes but clear about no distant spread.
- You don't have any metal implants or severe allergy that would make an MRI unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans to understand how tumor motion affects radiation therapy planning in lung cancer. It is for patients who are starting radiation treatment, possibly with chemotherapy or immunotherapy.
This trial uses advanced CT and MRI scans to make lung cancer screening more accurate and safer. It aims to better find and understand lung nodules, helping doctors decide if they are cancerous without unnecessary procedures.
This trial looks at whether doing an MRI scan of the brain for people with stage IV lung cancer helps in their care. The goal is to find brain issues early (if present) so treatment decisions can be made sooner.
This trial tests a new way of giving radiation therapy for advanced lung cancer that cannot be surgically removed. It uses MRI scans to guide and adjust the radiation dose, which may help target the tumor more precisely and reduce side effects.
This study tests whether using an MRI combined with a special type of CT scan can effectively monitor lung nodules over time. It may help people at high risk for lung cancer avoid repeated radiation from regular CT scans.
This study tests a special MRI to better understand suspicious spots on lung CT scans. The MRI may help tell if a spot is more likely to be cancer, which could reduce unnecessary procedures.
Hear when a new Lung Cancer (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.